Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 11:10:192.
doi: 10.3389/fneur.2019.00192. eCollection 2019.

The Impact of Cognitive and Behavioral Symptoms on ALS Patients and Their Caregivers

Jashelle Caga  1   2 , Sharpley Hsieh  3 , Patricia Lillo  4 , Kaitlin Dudley  5 , Eneida Mioshi  5
Affiliations
Review

The Impact of Cognitive and Behavioral Symptoms on ALS Patients and Their Caregivers

Jashelle Caga et al. Front Neurol. .

Abstract

Previously thought to be a pure motor disease, amyotrophic lateral sclerosis (ALS) is now established as multisystem neurodegenerative disorder that lies on a continuum with frontotemporal dementia (FTD). Cognitive and behavioral symptoms primarily extend to executive function, personality, social conduct, and emotion processing. The assessment and management of cognitive and behavioral symptoms is complicated as they must be differentiated from psychological responses to a terminal diagnosis and progressive physical impairment. This is made more difficult by the limited number of studies investigating how these symptoms specifically affect patients and caregivers well-being. The current review focuses on the impact of cognitive and behavioral symptoms on patient and caregiver well-being and their implications for future research and interventions in ALS. This is an important area of research that could form the basis for more tailored, and potentially more successful, non-pharmacological interventions to improve psychological well-being among patients with ALS and their caregivers.

Keywords: adherence; amyotrophic lateral sclerosis; burden; caregiver; dementia; depression; non-pharmacological interventions; quality of life.

PubMed Disclaimer

References

    1. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. . Amyotrophic lateral sclerosis. Lancet. (2011) 377:942–55. 10.1016/S0140-6736(10)61156-7 - DOI - PubMed
    1. Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, et al. . Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. (2013) 12:310–22. 10.1016/S1474-4422(13)70036-X - DOI - PMC - PubMed
    1. Strong MJ, Abrahams S, Goldstein LH, Woolley S, McLaughlin P, Snowden J, et al. . Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotr Lateral Scler Frontotemporal Degener. (2017) 18:153–74. 10.1080/21678421.2016.1267768 - DOI - PMC - PubMed
    1. Beeldman E, Raaphorst J, Klein Twennaar M, Govaarts R, Pijnenburg YAL, de Haan RJ, et al. . The cognitive profile of behavioural variant FTD and its similarities with ALS: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. (2018) 89:995–1002. 10.1136/jnnp-2017-317459 - DOI - PubMed
    1. Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. (2013) 12:368–80. 10.1016/S1474-4422(13)70026-7 - DOI - PubMed